Abbott Laboratories and Decom will concentrate on competing in the huge market of potential continuous glucose monitor technology and put any patent disputes behind them for 10 years. North ...

ADJUSTED EARNINGS: Stripping out certain one-time items, earnings are forecast to come in at $1.50 a share. That compares with adjusted earnings of $1.34 a share a year earlier. REVENUE: Quarterly ...

Abbott Laboratories reported a 4% increase in quarterly sales, totalling $10.4 billion. The company released its latest earnings report Thursday and subsequently revised its full-year financial ...

I analyzed Abbott Laboratories, a healthcare company with a diversified portfolio that includes pharmaceuticals, diagnostic products, nutritional products, and medical devices. I believe Abbott has ...

Abbott Lab's stock bucks a broad market selloff, after quarterly profit extends a long streak of beats on the back of strong demand for diabetes products Abbott Laboratories saw a big jump in demand ...

The consensus rating for Abbott Laboratories is Outperform, based on 3 analyst ratings. With an average one-year price target ...

Drugmaker AbbVie (NYSE: ABBV) spun off from Abbott Laboratories (NYSE: ABT) at the start of 2013. The growth-oriented pharma business has become a beast, generating more than $58 billion in revenue ...